Skip to main content
. 2023 Apr 3;11(4):1082. doi: 10.3390/biomedicines11041082

Table 1.

Characteristics of the patients and tumors.

Clinical Variable Patients, No. (%)
Patients 35 (100%)
Sex
      Male 18 (51%)
      Female 17 (49%)
Age, years
      1–10 29 (83%)
      >10 6 (17%)
Diagnosis
      Wilms tumor 14 (40%)
      Neuroblastoma 10 (29%)
      Ewing Sarcoma 4 (11%)
      Rhabdomyosarcoma 4 (11%)
      Others 3 (9%)
Tumor Volume
      <50 5 (14%)
      50–100 1 (3%)
      101–500 16 (46%)
      501–1000 8 (23%)
      >1000 4 (11%)
      Unknow 1 (3%)
Clinical Stage
      I 1 (3%)
      II 9 (26%)
      III 10 (29%)
      IV 13 (37%)
      Unknow 2 (6%)
Metastasis at diagnosis
      Yes 17 (49%)
      No 18 (51%)
Metastasis during the treatment
      Yes 11 (31%)
      No 19 (54%)
      Unknow 5 (14%)
cfDNA levels (ng/mL plasma)
      <10 10 (29%)
      10–50 13 (37%)
      51–100 6 (17%)
      >100 6 (17%)